Who owns Orchestra BioMed Holdings, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of OBIO from SEC Form 13F filings across 55 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 55 institutions disclosed 10.0M shares of Orchestra BioMed Holdings, Inc. worth $43.1M — about 15.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
55
13F holders
$43.1M
value, 2026 filers
15.7%
of shares outstanding (10.0M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of OBIO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2.5M | $10.8M | 0.0% | 3.9% | +294.9% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $8.7M | 0.0% | 3.2% | -54.1% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $4.4M | 0.0% | 1.6% | +107.6% |
| 4 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCNEW | 642,154 | $2.8M | 0.0% | 1% | new |
| 5 | Sixth Street Partners Management Company, L.P.NEW | 349,544 | $1.5M | 0.3% | 0.5% | new |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 349,544 | $1.5M | 0.0% | 0.5% | +31.7% |
| 7 | NORTHERN TRUST CORP | 343,640 | $1.5M | 0.0% | 0.5% | +190.5% |
| 8 | UBS Group AG | 325,773 | $1.4M | 0.0% | 0.5% | +547.5% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 292,253 | $1.3M | 0.0% | 0.5% | +24.2% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 274,973 | $1.2M | 0.0% | 0.4% | new |
| 11 | Knott David M Jr | 253,651 | $1.1M | 0.6% | 0.4% | 0.0% |
| 12 | Flat Footed LLCNEW | 251,372 | $1.1M | 0.1% | 0.4% | new |
| 13 | Simplify Asset Management Inc. | 219,387 | $946,655 | 0.0% | 0.3% | 0.0% |
| 14 | GOLDMAN SACHS GROUP INC | 179,606 | $775,000 | 0.0% | 0.3% | +15.7% |
| 15 | IFP Advisors, Inc | 89,608 | $386,659 | 0.0% | 0.1% | -9.4% |
| 16 | Bank of New York Mellon CorpNEW | 86,103 | $371,534 | 0.0% | 0.1% | new |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 65,804 | $283,944 | 0.0% | 0.1% | -32.5% |
| 18 | CITADEL ADVISORS LLC | 56,191 | $242,464 | 0.0% | 0.1% | -29.0% |
| 19 | Nuveen, LLCNEW | 52,118 | $224,889 | 0.0% | 0.1% | new |
| 20 | Holos Integrated Wealth LLC | 51,595 | $204,316 | 0.1% | 0.1% | 0.0% |
| 21 | NewEdge Advisors, LLC | 44,083 | $190,218 | 0.0% | 0.1% | 0.0% |
| 22 | Y-Intercept (Hong Kong) LtdNEW | 43,486 | $187,642 | 0.0% | 0.1% | new |
| 23 | DEUTSCHE BANK AG\NEW | 39,672 | $171,383 | 0.0% | 0.1% | new |
| 24 | WELLS FARGO & COMPANY/MNNEW | 36,356 | $156,876 | 0.0% | 0.1% | new |
| 25 | HighTower Advisors, LLC | 35,375 | $152,643 | 0.0% | 0.1% | +93.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.